British Cautious On Space Station Lab

LONDON—Britain may be moving out of step with its European partners over plans to take part in NASA's $12 billion space station. British space officials reported January 22 at an international conference sponsored by the Royal Society that Britain will urge a more cautious approach than that being advocated by the European Space Agency. The 13-member agency this year expects to draw up final plans for Columbus, its contribution to the U.S.-financed space station scheduled to be assembled i

Written byMichael Cross
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

British space officials reported January 22 at an international conference sponsored by the Royal Society that Britain will urge a more cautious approach than that being advocated by the European Space Agency. The 13-member agency this year expects to draw up final plans for Columbus, its contribution to the U.S.-financed space station scheduled to be assembled in the mid-1990s.

Columbus will consist of a pressurized module permanently attached to the core space station. It also will contain a free-flying polar platform, a man-tended free flyer with a small pressurized module and an unmanned platform.

A study commissioned by Britain's new space agency, the British National Centre, has enthusiastically backed Columbus. But the minister responsible for space policy, Geoffrey Pattie, warned that "we in Britain have succeeded in space through being hardheaded and by husbanding our resources skillfully."

Roy Gibson, director general of the British National Center, echoed the need for ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies